These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31696371)

  • 1. Efficacy is Not Everything: Eliciting Women's Preferences for a Vaginal HIV Prevention Product Using a Discrete-Choice Experiment.
    Browne EN; Montgomery ET; Mansfield C; Boeri M; Mange B; Beksinska M; Schwartz JL; Clark MR; Doncel GF; Smit J; Chirenje ZM; van der Straten A
    AIDS Behav; 2020 May; 24(5):1443-1451. PubMed ID: 31696371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Young Women's Stated Preferences for Biomedical HIV Prevention: Results of a Discrete Choice Experiment in Kenya and South Africa.
    Minnis AM; Browne EN; Boeri M; Agot K; van der Straten A; Ahmed K; Weinrib R; Mansfield C
    J Acquir Immune Defic Syndr; 2019 Apr; 80(4):394-403. PubMed ID: 30633040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating end-users' voices into the development of an implant for HIV prevention: a discrete choice experiment in South Africa and Zimbabwe.
    Browne EN; Manenzhe K; Makoni W; Nkomo S; Mahaka I; Ahmed K; Shapley-Quinn MK; Marton T; Luecke E; Johnson L; van der Straten A; Minnis AM
    BMC Womens Health; 2023 Feb; 23(1):58. PubMed ID: 36765358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent Preferences for HIV Prevention: A Discrete Choice Experiment for Multipurpose HIV Prevention Products in South Africa.
    Quaife M; Eakle R; Cabrera Escobar MA; Vickerman P; Kilbourne-Brook M; Mvundura M; Delany-Moretlwe S; Terris-Prestholt F
    Med Decis Making; 2018 Jan; 38(1):120-133. PubMed ID: 28863752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study.
    Montgomery ET; Beksinska M; Mgodi N; Schwartz J; Weinrib R; Browne EN; Mphili N; Musara P; Jaggernath M; Ju S; Smit J; Chirenje ZM; Doncel GF; van der Straten A
    J Int AIDS Soc; 2019 May; 22(5):e25283. PubMed ID: 31069957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights for Implementation Science From 2 Multiphased Studies With End-Users of Potential Multipurpose Prevention Technology and HIV Prevention Products.
    Minnis AM; Montgomery ET; Napierala S; Browne EN; van der Straten A
    J Acquir Immune Defic Syndr; 2019 Dec; 82 Suppl 3():S222-S229. PubMed ID: 31764258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study.
    Luecke EH; Cheng H; Woeber K; Nakyanzi T; Mudekunye-Mahaka IC; van der Straten A;
    J Int AIDS Soc; 2016; 19(1):20875. PubMed ID: 27247202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women's preferences for attributes of first-trimester miscarriage management: a stated preference discrete-choice experiment.
    Petrou S; McIntosh E
    Value Health; 2009 Jun; 12(4):551-9. PubMed ID: 18798807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferences for ARV-based HIV prevention methods among men and women, adolescent girls and female sex workers in Gauteng Province, South Africa: a protocol for a discrete choice experiment.
    Quaife M; Eakle R; Cabrera M; Vickerman P; Tsepe M; Cianci F; Delany-Moretlwe S; Terris-Prestholt F
    BMJ Open; 2016 Jun; 6(6):e010682. PubMed ID: 27354071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women's preferences for HIV prevention service delivery in pharmacies during pregnancy in Western Kenya: a discrete choice experiment.
    Mugambi ML; Odhiambo BO; Dollah A; Marwa MM; Nyakina J; Kinuthia J; Baeten JM; Weiner BJ; John-Stewart G; Barnabas RV; Hauber B
    J Int AIDS Soc; 2024 Jul; 27 Suppl 1(Suppl 1):e26301. PubMed ID: 38965978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. End-Users' Product Preference Across Three Multipurpose Prevention Technology Delivery Forms: Baseline Results from Young Women in Kenya and South Africa.
    Weinrib R; Minnis A; Agot K; Ahmed K; Owino F; Manenzhe K; Cheng H; van der Straten A
    AIDS Behav; 2018 Jan; 22(1):133-145. PubMed ID: 29052018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Couples' Preferences for "2 in 1" Multipurpose Prevention Technologies to Prevent Both HIV and Pregnancy: Results of a Discrete Choice Experiment in Uganda and Zimbabwe.
    Minnis AM; Etima J; Musara P; Browne EN; Mutero P; Kemigisha D; Mgodi NM; Nakabiito C; Shapley-Quinn MK; Stoner MCD; Hartmann M; Macagna N; Piper J; van der Straten A
    AIDS Behav; 2022 Dec; 26(12):3848-3861. PubMed ID: 35674885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Young Women's Ratings of Three Placebo Multipurpose Prevention Technologies for HIV and Pregnancy Prevention in a Randomized, Cross-Over Study in Kenya and South Africa.
    Minnis AM; Roberts ST; Agot K; Weinrib R; Ahmed K; Manenzhe K; Owino F; van der Straten A;
    AIDS Behav; 2018 Aug; 22(8):2662-2673. PubMed ID: 29560570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing access to PrEP based on MSM preferences: results of a discrete choice experiment.
    Dubov A; Ogunbajo A; Altice FL; Fraenkel L
    AIDS Care; 2019 May; 31(5):545-553. PubMed ID: 30554519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferences and Acceptability of Vaginal Delivery Forms for HIV Prevention Among Women, Male Partners and Key Informants in South Africa and Zimbabwe: Qualitative Findings.
    Musara P; Milford C; Shapley-Quinn MK; Weinrib R; Mutero P; Odoom E; Mgodi NM; Chirenje ZM; Hanif H; Clark MR; Smit J; van der Straten A; Montgomery ET;
    AIDS Behav; 2021 Jan; 25(1):124-138. PubMed ID: 32588257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient preference for a long-acting recombinant FSH product in ovarian hyperstimulation in IVF: a discrete choice experiment.
    van den Wijngaard L; Rodijk IC; van der Veen F; Gooskens-van Erven MH; Koks CA; Verhoeve HR; Mol BW; van Wely M; Mochtar MH
    Hum Reprod; 2015 Feb; 30(2):331-7. PubMed ID: 25432926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferred Product Attributes of Potential Multipurpose Prevention Technologies for Unintended Pregnancy and Sexually Transmitted Infections or HIV Among U.S. Women.
    Hynes JS; Sheth AN; Lathrop E; Sales JM; Haddad LB
    J Womens Health (Larchmt); 2019 May; 28(5):665-672. PubMed ID: 30615569
    [No Abstract]   [Full Text] [Related]  

  • 18. Perceptions of the "Fabric" - An exploratory study of a novel multi-purpose technology among women in Sub Saharan Africa.
    Laborde ND; Leslie J; Krogstad E; Morar N; Mutero P; Etima J; Woodrow K; van der Straten A
    PLoS One; 2018; 13(10):e0204821. PubMed ID: 30379839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of adverse information and positive promotion on women's preferences for prescribed contraceptive products.
    Knox SA; Viney RC; Gu Y; Hole AR; Fiebig DG; Street DJ; Haas MR; Weisberg E; Bateson D
    Soc Sci Med; 2013 Apr; 83():70-80. PubMed ID: 23351426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How much demand for New HIV prevention technologies can we really expect? Results from a discrete choice experiment in South Africa.
    Terris-Prestholt F; Hanson K; MacPhail C; Vickerman P; Rees H; Watts C
    PLoS One; 2013; 8(12):e83193. PubMed ID: 24386160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.